May 2023 in “Journal of Cosmetic and Laser Therapy” This research observed that combination therapy targeting different pathogenetic pathways is more effective than monotherapy in treating female pattern hair loss, offering a more aggressive treatment approach that can include modalities such as minoxidil, spironolactone, and finasteride.
July 2021 in “Journal of dermatology research and therapy” In this study, researchers observed an increased incidence of pattern hair loss and telogen effluvium among COVID-19 patients, potentially linked to psychological stress, systemic inflammation, and oxidative stress, with reduced anagenic expression of proteoglycans suggested as a mediating mechanism.
This review discusses the association between alopecia and increased cardiovascular and metabolic risk but reports no definitive clinical results, emphasizing the need for more comprehensive studies on androgenetic alopecia patients.
January 2014 in “Journal of Physiology & Pathology in Korean Medicine” Microneedle roller therapy can help hair grow.
May 2009 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature” DHEA therapy improved pubic hair growth and psychological well-being in young females with adrenal insufficiency.
February 2008 in “Medical & surgical dermatology” Some treatments like topical oxygen and stem cells show promise for wound healing and hair growth, but evidence for modern dressings over traditional ones is limited.
April 2023 in “Journal of Investigative Dermatology” This study found that autologous cell-based therapy using dermal sheath cup cells showed a moderate increase in hair volume in patients with pattern hair loss, particularly in women.
October 2022 in “Hair Transplantation” Medical treatments like minoxidil and finasteride are important for improving hair loss and quality of life.
December 2020 in “Journal of The American Academy of Dermatology” In this study, machine learning models showed high accuracy in predicting therapeutic outcomes for female pattern hair loss, highlighting the significant impact of age of onset and condition duration on treatment response.
June 2026 in “Mendeley Data” This source presents the Drug Database for Hair Loss Disorders, offering comprehensive details about pharmacological agents for treating hair loss conditions, including information on chemical properties, efficacy, and safety, aimed at supporting research and drug development.
June 2026 in “Mendeley Data” This study introduced the Drug Database for Hair Loss Disorders, which provides comprehensive details on pharmacological agents used to treat hair loss conditions, aiding research and development efforts in drug companies through accessible chemical properties, mechanisms, and efficacy data.
October 2017 in “Doctoral thesis, UCL (University College London).” This study developed and tested nanostructured lipid carriers for topical dutasteride delivery, finding them stable, low in cytotoxicity and non-irritating, with no drug permeation through pig ear skin over 48 hours.
December 2016 in “Clinics in surgery” This article reviews the epidemiology, pathophysiology, and management of androgenetic alopecia, highlighting recent insights into stem cell niches in hair follicles without presenting new experimental findings.
14 citations
,
September 2017 in “Proteomics. Clinical applications” This review discusses advancements and gaps in using proteomics for hair testing and its potential in developing a medical proteome repository, but reports no new research findings.
12 citations
,
May 2019 in “Journal of cosmetic dermatology” This review explores the factors contributing to premature graying of hair, highlighting the role of genetic and environmental influences such as oxidative stress, and discusses potential interventions like diet and herbal remedies, while noting the limitations of common treatments like hair dyes.
September 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This study introduces the MHS Hair Restoration Protocol, a systems-biology model targeting hair follicle health through the gut-microbiome-endocannabinoidome axis and innovative topical treatments, emphasizing a holistic approach to pattern hair loss.
September 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This research introduces the MHS Hair Restoration Protocol, which is a comprehensive approach aimed at restoring the hair follicle environment by modulating the gut-microbiome-endocannabinoidome axis and incorporating specific dietary and topical strategies, rather than focusing only on short-term hair count improvements.
August 2026 in “British Journal of Dermatology” sCD83 shows promise for treating hair loss by promoting growth and reducing inflammation.
July 2026 in “Cell Communication and Signaling” This review discusses the aging process of hair follicle stem cells and their niche, focusing on degradation mechanisms and potential therapeutic strategies, but it reports no new results.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review highlights the therapeutic potential of Ziziphus mauritiana and Black Seed Oil in herbal hair care products, reporting their antioxidant, antimicrobial, and anti-inflammatory properties, which may help address issues like hair fall and scalp irritation while serving as promising natural alternatives to synthetic solutions.
May 2026 in “Zenodo (CERN European Organization for Nuclear Research)” This review concludes that herbal formulations containing Ziziphus mauritiana and Black Seed Oil may offer a promising natural alternative for managing hair-related issues like dandruff, hair fall, and scalp irritation.
May 2026 in “International Journal of Drug Delivery Technology” This study found that high leukocyte platelet-rich plasma was more effective in increasing hair density and patient satisfaction for androgenetic alopecia treatment.
July 2025 in “World Journal of Stem Cells” This review highlights that exosome-based therapies show promise for hair regeneration by modulating signaling pathways and enhancing hair follicle regeneration; however, further clinical research is needed due to variability in methods and limited clinical studies.
February 2025 in “Dermatologic Surgery” This review highlights the expanding medical applications of follicular unit excision, suggesting it might be effective for conditions like chronic ulcers, axillary hyperhidrosis, bromhidrosis, vitiligo, and scar remodeling, although further research is needed.
September 2017 in “Journal of Clinical Dermatology” This study found that applying a growth factor cocktail including FGF9 with microneedling significantly increased hair density and diameter in patients with androgenetic alopecia, with similar results regardless of microneedle depths between 0.5 mm and 0.8 mm.
January 2021 in “Journal of cosmetology & trichology” In this follow-up study, participants with severe androgenic/estrogenic alopecia showed increased hair growth 10 months after ending vacuum therapy and cosmetic emulsion treatment, highlighting the therapies' potential effectiveness.
21 citations
,
August 2013 in “Journal of Dermatological Treatment” This review discusses the mixed evidence and high risk of bias in studies on low-level light therapy for treating androgenetic alopecia and calls for rigorous randomized controlled trials to assess its efficacy.
15 citations
,
June 2015 in “Lasers in Medical Science” This study found that low-level laser therapy with an 830-nm wavelength most significantly stimulated hair growth in rats, compared to other wavelengths tested.
14 citations
,
August 2013 in “Facial Plastic Surgery Clinics of North America” This review discusses current and emerging medical therapies for androgenetic alopecia but reports no new clinical findings, emphasizing the importance of stabilizing the condition as a complement to surgical hair restoration.
13 citations
,
May 2005 in “Seminars in Plastic Surgery” This article discusses the cell therapy potential of follicular cell implantation for hair regeneration and reports no new clinical results, emphasizing the role of dermal papilla cells in forming new follicles.